Suppr超能文献

关于失眠的精神病学视角。

A psychiatric perspective on insomnia.

作者信息

McCall W V

机构信息

Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

出版信息

J Clin Psychiatry. 2001;62 Suppl 10:27-32.

Abstract

Insomnia is a cardinal symptom for many psychiatric disorders, especially depressive disorders. Treatment of the underlying psychiatric disorder may be sufficient to relieve the accompanying insomnia. If the insomnia fails to respond, then consideration should be given to the possibility of inadequate treatment of the primary psychiatric disorder, iatrogenic insomnia, insomnia related to a medical disorder, or learned/habit insomnia. Persistent insomnia should be aggressively pursued, since it has been associated with a variety of adverse outcomes in samples of depressed patients. The physician should always inquire about and encourage healthy sleeping behaviors, even if hypnotic medication is contemplated. Benzodiazepines and nonbenzodiazepine benzodiazepine receptor agonists (BzRAs) have the best evidence for efficacy as hypnotics, although sedating antidepressants are popularly prescribed. Although all benzodiazepine hypnotics and nonbenzodiazepine BzRAs are comparably efficacious in inducing sleep, they vary markedly in their potential for residual side effects.

摘要

失眠是许多精神疾病尤其是抑郁症的主要症状。治疗潜在的精神疾病可能足以缓解伴随的失眠。如果失眠没有得到改善,则应考虑原发性精神疾病治疗不足、医源性失眠、与躯体疾病相关的失眠或习得性/习惯性失眠的可能性。应积极治疗持续性失眠,因为在抑郁症患者样本中,它与多种不良后果相关。即使考虑使用催眠药物,医生也应始终询问并鼓励健康的睡眠行为。苯二氮䓬类药物和非苯二氮䓬类苯二氮䓬受体激动剂(BzRAs)作为催眠药的疗效证据最为充分,尽管镇静性抗抑郁药也被广泛使用。虽然所有苯二氮䓬类催眠药和非苯二氮䓬类BzRAs在诱导睡眠方面疗效相当,但它们在残留副作用的可能性上有显著差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验